Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased RBP4 in a human model of activated anti-atherosclerotic and antiremodelling defences.

European journal of clinical investigation - 1 Jun 2014

Calò Lorenzo A, Maiolino Giuseppe, Pagnin Elisa, Vertolli Ugo, Davis Paul A

Abstract excerpt

BACKGROUND: Both increased and decreased levels of the adipokine retinol-binding protein 4 (RBP4) have been reported in cardiovascular disease, and levels of RBP4 have been related to diabetes, metabolic syndrome and cardiovascular risk. Recently, clear in vitro and ex vivo vasodilatory and inhibitory of platelet activation effects of RBP4 has been shown and a reduced RBP4 level was found in high cardiovascular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bartter Syndrome
Share to Gitelman Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heme Oxygenase-1

Share to Models, Cardiovascular

Share to Retinol-Binding Proteins, Plasma

Share to Solute Carrier Family 12, Member 3

Share to Vascular Remodeling

Share to Vasodilation

Source

Identifiers

PMID: 24739026
DOI: 10.1111/eci.12270

Genes

RBP4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased RBP4 in a human model of activated anti-atherosclerotic and antiremodelling defences.PMID 24739026Read ↗

FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide.Semantic proximity Read ↗

The therapeutic potential of BRD4 in cardiovascular diseaseSemantic proximity Read ↗

RGS proteins: identifying new GAPs in the understanding of blood pressure regulation and cardiovascular function.Semantic proximity Read ↗

Maternal Retinoids Increase PDGFRα+ Progenitor Population and Beige Adipogenesis in Progeny by Stimulating Vascular DevelopmentSemantic proximity Read ↗

Atherogenicindex of plasma (AIP)as a Novel Biomarker to Predict Retinal Vein OcclusionSemantic proximity Read ↗

Regulators of G protein signaling in cardiovascular function during pregnancy.Semantic proximity Read ↗

Anti-oxidative treatment with vitamin E improves peripheral vascular function in patients with diabetes mellitus and Haptoglobin 2-2 genotype: A double-blinded cross-over study.Semantic proximity Read ↗

Phoenixin 20 Prevents ox-LDL-Induced Attachment of Monocytes to Human Aortic Endothelial cells (HAECs): A Protective Implication in AtherosclerosisSemantic proximity Read ↗

Elevated resting heart rate as a predictor of inflammation and cardiovascular risk in healthy obese individuals.Semantic proximity Read ↗

The prevention and treatment of hypoadiponectinemia-associated human diseases by up-regulation of plasma adiponectin.Semantic proximity Read ↗

Elevated Resting Heart Rate is Associated with Increased Circulatory CD14 + TLR4 + monocytes and VEGF Expression in Healthy Obese Individuals: Implications for Inflammation and Cardiovascular DiseaseSemantic proximity Read ↗

Vitamin C blocks vascular dysfunction and release of interleukin-6 induced by endothelin-1 in humans in vivoSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.